Archiv der Pharmazie p. 689 - 698 (1995)
Update date:2022-08-05
Topics:
Monge
Navarro
Font
Santiago
Alberdi
Martinez-Irujo
This paper presents the synthesis of new indole, pyridazino[4,5-b]-indole, and pyridazino[4,5-a]indole analogs were as well as a study of their 'in vitro' activity as inhibitors of different phosphodiesterases isolated from dog cardiac tissue, dog aorta, and bovine platelets; the study of their activity as inhibitors of platelet aggregation in guinea pig whole blood, with ADP and arachidonic acid (AA) as pro-aggregants, is also included. The selected compounds 8-benzyloxy-3,4-dihydro-1-(3,4,5-trimethoxy)benzylideneaminopyridazino [4,5-b]indole 14g, and 8-benzyloxy-4-[(3,5-dimethyl)pyrazolyl]pyridazino(4,5-b]indole 20 present an interesting profile as potential inodilators, with a complementary, beneficial activity as inhibitors of the aggregation, activities which could possibly be related to the inhibition of the PDE's. Among the other compounds studied, 8-benzyloxy-3,4-dihydro-1-[4-(methyl)piperazino]acetamidopyridazino[4, 5-b]indol-4-one 16c and 8-benzyloxy-3,4-dihydro-1-[4-(2-methoxyphenyl)piperazino]acetamidopyri dazino[4,5-b]indol-4-one 16f stood out as inhibitors of platelet aggregation, with a mechanism that could possibly be related to the AA cascade.
View MoreHangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
LianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
Shantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Shanghai PotentPharm Science and Technology Co.,Ltd
Contact:86-021-51969655
Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Doi:10.1016/S0040-4020(01)82424-8
(1984)Doi:10.1002/jhet.5570390615
(2002)Doi:10.1055/s-1984-30840
(1984)Doi:10.1016/S0040-4039(01)80251-3
(1984)Doi:10.1002/open.201700087
(2017)Doi:10.1039/b612611a
(2006)